EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity

Fulvia Ceccarelli, Francesco Natalucci, Alessandra Di Filippo, Giulio Olivieri, Chiara Napoletano, Aurelia Rughetti iD, Marianna Nuti, Ilaria Grazia Zizzari iD, Fabrizio Conti

Journal of Immunology Research · 2023

DOI: 10.1155/2023/2344239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2023. Verfasst von Fulvia Ceccarelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lupus Clinic, Rheumatology Unit, Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, …. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The role of T cells in the pathogenesis of systemic lupus erythematosus (SLE) has recently gained attention. Costimulatory molecules are membrane proteins strictly associated with T-cell receptor (TCR), acting by activating or inhibiting T cells and antigen-presenting cells (APC) through direct and reverse signaling, thus becoming responsible for the development of effector T cells or regulatory T cells. The primary objective of the present case–control study was to evaluate the cell membrane expression of CD137 on T cells and the serum concentration of CD137 (sCD137) in a SLE cohort. Materials. We enrolled SLE patients and sex/age-matched healthy subjects (HS). Disease activity was assessed by SLEDAI-2K. By application of flow cytometry, we evaluated the expression of CD137 on CD4+ and CD8+ lymphocytes. ELISA test was performed to evaluate serum levels of sCD137.

Results

Twenty-one SLE patients (M/F 1/20; median age 48 years (IQR 17); median disease duration 144 months (IQR 204)) were evaluated. SLE patients showed %CD3+CD137+ cells significantly higher compared to HS (median 5.32 (IQR 6.11) versus 3.3 (IQR 1.8), p = 0.001 ). In SLE patients, %CD4+CD137+ cells positively correlated with SLEDAI-2K ( p = 0.0082 , r = 0.58, CI (0.15–0.82); indeed, %CD4+CD137+ cells were significantly lower in SLE patients with a remission status compared to those not reaching this condition (median 1.07 (IQR 0.91) versus 1.58 (IQR 2.42), p = 0.013 ). Accordingly, sCD137 levels were significantly lower in remission status (31.30 pg/mL (IQR 102.2 versus median 122.8 pg/mL (IQR 536); p = 0.03 ) and correlated with %CD4+CD137+ cells ( p = 0.012 , r = 0.60, CI (0.15–0.84)).

Conclusion

Our results suggest a possible involvement of CD137-CD137L axis in SLE pathogenesis, as demonstrated by higher expression of CD137 on CD4+ cells in SLE compared with HS. Furthermore, the positive correlation between SLEDAI-2K and membrane CD137 expression on CD4+ cells, as well as soluble CD137, indicates a possible use as biomarkers for disease activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesLupus Erythematosus, SystemicHumansMiddle AgedBiomarkersCD8-Positive T-LymphocytesT-Lymphocytes, RegulatoryTumor Necrosis Factor Receptor Superfamily, Member 9

Substanzen

BiomarkersTumor Necrosis Factor Receptor Superfamily, Member 9

Autor:innen und Institutionen

  • Lupus Clinic, Rheumatology Unit, Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
  • Laboratory of Tumor Immunology and Cell Therapy, Department of Experimental Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Aurelia Rughetti, Ilaria Grazia Zizzari

Zitieren

APA

Ceccarelli, F., Natalucci, F., Di Filippo, A., Olivieri, G., Napoletano, C., Rughetti, A., Nuti, M., Zizzari, I. G., & Conti, F. (2023). Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity. Journal of Immunology Research. https://doi.org/10.1155/2023/2344239

Vancouver

Ceccarelli F, Natalucci F, Di Filippo A, Olivieri G, Napoletano C, Rughetti A, et al. Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity. Journal of Immunology Research. 2023. doi:10.1155/2023/2344239

BibTeX
@article{Ceccarelli2023,
  author = {Ceccarelli, Fulvia and Natalucci, Francesco and Di Filippo, Alessandra and Olivieri, Giulio and Napoletano, Chiara and Rughetti, Aurelia and Nuti, Marianna and Zizzari, Ilaria Grazia and Conti, Fabrizio},
  title = {Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity},
  journal = {Journal of Immunology Research},
  year = {2023},
  doi = {10.1155/2023/2344239}
}
Kostenlos starten →